<DOC>
	<DOCNO>NCT02022111</DOCNO>
	<brief_summary>To provide good care preventive service people depression diabetes , investigator propose develop test whether intervention reduce depressive symptom integrate routine diabetes clinic India . The investigator gather feedback patient India focus group discussion individual interview culturally-adapt model combine depression diabetes care . The investigator evaluate effectiveness cost care model trial three diabetes clinic India . It expect result study guide incorporate mental health care routine diabetes clinic low-resource setting .</brief_summary>
	<brief_title>INtegrating DEPrEssioN Diabetes treatmENT ( INDEPENDENT ) Study</brief_title>
	<detailed_description>It show target depression diabetes control important synergistic benefit . Since diabetes patient India tend access specialist ( government private ) diabetes health care need , least point contact health system leverage also reduce depressive symptom . The investigator aim assess intervention depression integrate routine diabetes care delivery modest modification . The integrated multi-condition ( depression diabetes ) intervention model merges experience TEAMCare ongoing trial cardiovascular disease ( CVD ) risk reduction India ( CARRS Trial ) involve : 1. enhance role care coordinator train disease management ; 2. integrate 'intelligent ' technology ; 3. weekly physician oversight review poorly-controlled case make responsive treatment adjustment . The investigator propose take model research practice use implementation science approach . The investigator first gather formative qualitative data endeavor make intervention patient-centered , develop locally-understandable educational material , identify way overcome stigma mental health disorder facilitate trustful therapeutic relationship care coordinator patient family . The investigator evaluate effectiveness cost-effectiveness intervention model randomize control trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Age ≥35 year Confirmed diagnosis diabetes ( document glucose tolerance test 2 venous glucose level ) PHQ9 score≥10 ≥1 poorlycontrolled CVD risk factor ( either HbA1c≥8.0 % SBP≥140 mmHg LDL≥130 mg/dl ) , irrespective medication use Willingness consent randomization . The patient report `` 3 '' PHQ9 questionnaire suicide item ( Item No:9 ) reflect high suicide risk patient 's PHQ9 score 23 indicate severe depression require immediate referral Any participant reporting `` 2 '' PHQ9 suicide item ( Item No:9 ) review carefully consider high risk , participant exclude enrollment trial refer intensive psychiatric care . Already psychiatrist 's care use antipsychotic mood stabilizer medication diagnose dementia bipolar disorder schizophrenia ( base bipolar schizophrenia module MINI ) Diabetes secondary uncommon cause ( e.g. , chronic pancreatitis ) Pregnancy breastfeed Documented CVD event ( MI , stroke ) past 12 month Endstage renal disease await transplant Malignancy lifethreatening disease death probable 3 year Alcohol drug abuse No fix address contact detail .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>